Literature DB >> 29787373

Gynecological organ involvement at robot-assisted radical cystectomy in females: Is anterior exenteration necessary?

Michelle Whittum1, Ahmed Aly Hussein1, Youssef E Ahmed1, Hijab Khan1, Collin Krasowski1, Neil B Huben1, Paul R May1, Tomoaki Terakawa2, Qiang Li1, Khurshid A Guru1.   

Abstract

INTRODUCTION: We aimed to investigate patient and disease variables associated with gynecological organ invasion in females with bladder cancer at the time of robot-assisted radical cystectomy (RARC).
METHODS: We conducted a retrospective review of female patients who underwent robot-assisted anterior pelvic exenteration (RAAE) between 2005 and 2016. Patients were divided into two groups: those with gynecological organ involvement at RAAE and those without. Data were reviewed for perioperative and pathological outcomes. Kaplan-Meier method was used to depict survival outcomes. Multivariable stepwise regression analysis was performed to identify predictors of gynecological organ involvement.
RESULTS: A total of 118 female patients were identified; 17 (14%) showed evidence of gynecological organ invasion at RAAE. Patients with gynecological organ invasion had more lymphovascular invasion at transurethral resection of bladder tumour (TURBT) (82% vs. 46%; p=0.006), trigonal tumours at TURBT (59% vs. 18%; p=0.001), multifocal disease (65% vs. 33%; p=0.01), pN+ (71% vs. 22%; p<0.001), positive surgical margins (24% vs. 4%; p=0.02), and they less commonly demonstrated pure urothelial carcinoma at TURBT (18% vs. 66%; p<0.001). On multivariate analysis, significant predictors of gynecological organ invasion were pN positive disease (odds ratio [OR] 6.48; 95% confidence interval [CI] 1.64-25.51; p=0.008), trigonal tumour location (OR 5.72; 95% CI 1.39-23.61; p=0.02), and presence of variant histology (OR18.52; 95% CI 3.32-103.4; p=0.001).
CONCLUSIONS: Patients with trigonal tumours, variant histology, and nodal involvement are more likely to have gynecological organs invasion at RAAE. This information may help improve counselling of patients and better identify candidates for gynecological organ-sparing cystectomy.

Entities:  

Year:  2018        PMID: 29787373      PMCID: PMC6143501          DOI: 10.5489/cuaj.5086

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  24 in total

1.  Pregnancy in women with ureterosigmoidostomy.

Authors:  Bjoern G Volkmer; Evelyn M Seidl; Juergen E Gschwend; Robert de Petriconi; Dietmar Bach; Klaus Kleinschmidt
Journal:  Urology       Date:  2002-12       Impact factor: 2.649

2.  Preservation of the internal genital organs during radical cystectomy in selected women with bladder cancer: a report on 15 cases with long term follow-up.

Authors:  B Ali-El-Dein; A Mosbah; Y Osman; N El-Tabey; M Abdel-Latif; I Eraky; A A Shaaban
Journal:  Eur J Surg Oncol       Date:  2013-02-17       Impact factor: 4.424

3.  Uterus-, fallopian tube-, ovary-, and vagina-sparing cystectomy followed by U-shaped ileal neobladder construction for female bladder cancer patients: oncological and functional outcomes.

Authors:  Takuya Koie; Shingo Hatakeyama; Takahiro Yoneyama; Yasuhiro Hashimoto; Noritaka Kamimura; Chikara Ohyama
Journal:  Urology       Date:  2009-12-06       Impact factor: 2.649

4.  Secondary malignant involvement of gynecologic organs in radical cystectomy specimens in women: is it mandatory to remove these organs routinely?

Authors:  Bedeir Ali-El-Dein; Mohamed Abdel-Latif; Ahmed Mosbah; Ibrahim Eraky; Atallah A Shaaban; Noheir M Taha; Mohamed A Ghoneim
Journal:  J Urol       Date:  2004-09       Impact factor: 7.450

5.  Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United States.

Authors:  Jeffrey J Leow; Stephen W Reese; Wei Jiang; Stuart R Lipsitz; Joaquim Bellmunt; Quoc-Dien Trinh; Benjamin I Chung; Adam S Kibel; Steven L Chang
Journal:  Eur Urol       Date:  2014-01-28       Impact factor: 20.096

6.  Gynecologic-tract sparing extra peritoneal retrograde radical cystectomy with neobladder.

Authors:  Jagdeesh N Kulkarni; S Jamal Rizvi; U Purushotthama Acharya; K S Shiva Kumar; P Tiwari
Journal:  Int Braz J Urol       Date:  2008 Mar-Apr       Impact factor: 1.541

7.  Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.

Authors:  J Alfred Witjes; Thierry Lebret; Eva M Compérat; Nigel C Cowan; Maria De Santis; Harman Maxim Bruins; Virginia Hernández; Estefania Linares Espinós; James Dunn; Mathieu Rouanne; Yann Neuzillet; Erik Veskimäe; Antoine G van der Heijden; Georgios Gakis; Maria J Ribal
Journal:  Eur Urol       Date:  2016-06-30       Impact factor: 20.096

8.  Reproductive organ involvement in female patients undergoing radical cystectomy for urothelial bladder cancer.

Authors:  Hooman Djaladat; H Maxim Bruins; Gus Miranda; Jie Cai; Eila C Skinner; Siamak Daneshmand
Journal:  J Urol       Date:  2012-10-18       Impact factor: 7.450

9.  Surgical and psychosexual outcome following vaginal reconstruction with pelvic exenteration.

Authors:  N Gleeson; W Baile; W S Roberts; M Hoffman; J V Fiorica; D Barton; D Cavanagh
Journal:  Eur J Gynaecol Oncol       Date:  1994       Impact factor: 0.196

10.  Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.

Authors:  Syed Johar Raza; Timothy Wilson; James O Peabody; Peter Wiklund; Douglas S Scherr; Ali Al-Daghmin; Shiva Dibaj; Muhammad Shamim Khan; Prokar Dasgupta; Alex Mottrie; Mani Menon; Bertram Yuh; Lee Richstone; Matthias Saar; Michael Stoeckle; Abolfazl Hosseini; Jihad Kaouk; James L Mohler; Koon-Ho Rha; Gregory Wilding; Khurshid A Guru
Journal:  Eur Urol       Date:  2015-05-16       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.